Corrigendum: SGLT2 inhibitors suppress epithelial-mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway

Detalles Bibliográficos
Autores principales: Guo, Ruixue, Wang, Peipei, Zheng, Xuejun, Cui, Wen, Shang, Jin, Zhao, Zhanzheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815602/
https://www.ncbi.nlm.nih.gov/pubmed/36618948
http://dx.doi.org/10.3389/fphar.2022.1074294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815602/
https://www.ncbi.nlm.nih.gov/pubmed/36618948
http://dx.doi.org/10.3389/fphar.2022.1074294

Ejemplares similares